The ERShares Private-Public Crossover ETF (XOVR) has seen a surge in investment due to its unique exposure to SpaceX, ahead of the company's potential record-breaking IPO.

First-time share sales in the U.S. this year have raised a combined $46.15 billion — excluding blank-check firms — the ...

The ERShares Private-Public Crossover ETF (ticker XOVR) has taken in more than $470 million since December 8 — more than half its total assets ...

OpenAI is in early talks to raise up to $100 billion at a $750 billion valuation, while also preparing for a potential $1 ...

SpaceX is weighing a historic IPO that could launch Elon Musk’s rocket company past OpenAI as the world’s most valuable ...

SpaceX could go public as early as 2026 and emerge as one of the world's most valuable listed companies, with market ...

One of the more intriguing headlines to surface recently is the growing expectation that SpaceX, Elon Musk’s space and ...

SpaceX might seek to raise $30 billion and value the company at $1.5 trillion. The money would be used partly to accelerate ...

A bid by individual investors to grab a sliver of SpaceX before it goes public has propelled a niche ETF into the spotlight, ...

The shares are indicated at $33.50 each, versus the IPO price of $29. Medline, which counts Blackstone Inc., Carlyle Group ...

Medline's public debut on Wednesday caps the best IPO year since 2021, with Wall Street optimistic on the deals outlook ...

Medline shares rose 20.7% in their hotly anticipated New York debut on Wednesday, valuing the medical supply giant at $46 ...